ArticleRheumatology international2022
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol.
Open access · bronzeAbstract read
In one paragraph
Article in Rheumatology international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.2field-weighted citation impact, top 6% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 51 citations in OpenAlex.
- Health Information-seeking Behavior in Patients with Antiphospholipid Syndrome: A Scoping Review with Original Data.Current rheumatology reports · 2026Review
- Differentiating the COVID-19 Infection and Vaccine Experiences of Patients With Systemic, Single Organ, and Overlap Immune-Mediated Inflammatory Disease: Protocol for a Secondary Analysis for Enhancing COVID-19 Vaccine Pharmacovigilance.JMIR research protocols · 2026Article
- First Report of the Immunogenicity of an Inactivated SARS-CoV-2 (COVID-19) Vaccine in Iranian Patients with Autoimmune Diseases.European journal of rheumatology · 2025Article
- Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study.Rheumatology advances in practice · 2025Article
- Disease burden in inflammatory arthritis: an unsupervised machine learning approach of the COVAD-2 e-survey dataset.Rheumatology advances in practice · 2025Article
- Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study.Rheumatology international · 2024Article
- COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study.Rheumatology international · 2024Article
- Health Status and COVID-19 Epidemiology in an Inland Region of Portugal: A Retrospective Study.International journal of environmental research and public health · 2024Article
- Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies.Rheumatology international · 2024Article
- Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study.Rheumatology international · 2024Article
- Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey.Rheumatology international · 2024Article
- Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study.Journal of diabetes investigation · 2024Article
- COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.Rheumatology international · 2024Article
- High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey.Rheumatology international · 2023Article
- Symptom flares after COVID-19 infection versus vaccination among youth with PANS/PANDAS.Allergy and asthma proceedings · 2023Article
- Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.Rheumatology (Oxford, England) · 2023Article
- Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey.Rheumatology international · 2023Article
- COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey.Rheumatology international · 2023Article
- TNF inhibitors significantly attenuate the humoral immune response to COVID-19 vaccination in patients with rheumatoid arthritis.Rheumatology advances in practice · 2023Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors at 20 institutions in 17 countries.
Parikshit SenMaulana Azad Medical College, 2-Bahadurshah Zafar Marg, New Delhi, Delhi, 110002, India.ORCID 0000-0002-1630-6026
Latika GuptaDepartment of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Rae Bareilley Road, Lucknow, 226014, India. drlatikagupta@gmail.com.ORCID 0000-0003-2753-2990
James B LillekerDivision of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.ORCID 0000-0002-9230-4137
Vishwesh AggarwalMahatma Gandhi Mission Medical College, Navi Mumbai, Maharashtra, India.ORCID 0000-0002-0986-8354
Sinan KardesDepartment of Medical Ecology and Hydroclimatology, Istanbul Faculty of Medicine, Istanbul University, Capa-Fatih, Istanbul, 34093, Turkey.ORCID 0000-0002-6311-8634
Marcin MilchertDepartment of Rheumatology, Internal Medicine, Geriatrics and Clinical Immunology, Pomeranian Medical University, ul Unii Lubelskiej 1, 71-252, Szczecin, Poland.ORCID 0000-0002-0943-8768
Tamer GheitaRheumatology Department, Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.ORCID 0000-0002-1155-9729
Babur SalimRheumatology Department, Fauji Foundation Hospital, Rawalpindi, Pakistan.ORCID 0000-0001-8430-9299
Tsvetelina VelikovaDepartment of Clinical Immunology, Medical Faculty, University Hospital "Lozenetz", Sofia University St. Kliment Ohridski, 1 Kozyak Str., Sofia, 1407, Bulgaria.ORCID 0000-0002-0593-1272
Abraham Edgar Gracia-RamosDepartment of Internal Medicine, General Hospital, National Medical Center "La Raza", Instituto Mexicano del Seguro Social, Av. Jacaranda S/N, Col. La Raza, Del. Azcapotzalco, C.P. 02990, Mexico City, Mexico.ORCID 0000-0003-1842-2554
Ioannis ParodisDivision of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0002-4875-5395
Albert Selva O'CallaghanInternal Medicine Department, Vall D'hebron General Hospital, Universitat Autonoma de Barcelona, 08035, Barcelona, Spain.ORCID 0000-0003-2823-9761
Elena NikiphorouCentre for Rheumatic Diseases, King's College London, London, UK.ORCID 0000-0001-6847-3726
Ai Lyn TanNIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust, Leeds, UK.ORCID 0000-0002-9158-7243
Lorenzo CavagnaRheumatology Unit, Dipartimento di Medicine Interna e Terapia Medica, Università Degli Studi di Pavia, Pavia, Lombardy, Italy.ORCID 0000-0003-3292-1528
Miguel A SaavedraDepartamento de Reumatología Hospital de Especialidades Dr. Antonio Fraga Mouret, Centro Médico Nacional La Raza, IMSS, Mexico City, Mexico.ORCID 0000-0003-0687-9944
Samuel Katsuyuki ShinjoDivision of Rheumatology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, São Paulo, SP, Brazil.ORCID 0000-0002-3682-4517
Nelly ZiadeRheumatology Department, Saint-Joseph University, Beirut, Lebanon.ORCID 0000-0002-4479-7678
Johannes KnitzaMedizinische Klinik 3 - Rheumatologie und Immunologie, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Ulmenweg 18, 91054, Erlangen, Germany.ORCID 0000-0001-9695-0657
Masataka KuwanaDepartment of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8602, Japan.ORCID 0000-0001-8352-6136
Giovanni CagnottoRheumatology, Department of Clinical Sciences, Lund University, Malmö, Sweden.ORCID 0000-0002-1682-8158
Arvind NuneSouthport and Ormskirk Hospital NHS Trust, Southport, PR8 6PN, UK.ORCID 0000-0002-3849-614X
Oliver DistlerDepartment of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-0546-8310
Hector ChinoyDivision of Musculoskeletal and Dermatological Sciences, Centre for Musculoskeletal Research, School of Biological Sciences, The University of Manchester, Manchester, UK.ORCID 0000-0001-6492-1288
Vikas AggarwalDepartment of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Rae Bareilley Road, Lucknow, 226014, India.ORCID 0000-0002-2089-027X
Rohit AggarwalDivision of Rheumatology and Clinical Immunology, Department of Medicine, UPMC Arthritis and Autoimmunity Center, School of Medicine, University of Pittsburgh, 3601 Fifth Ave., Suite 2B, Pittsburgh, PA, 15213, USA. aggarwalr@upmc.edu.ORCID 0000-0001-7531-8038
COVAD Study Group
Manchester Academic Health Science Centre · GBSanjay Gandhi Post Graduate Institute of Medical Sciences · INUniversitat Autònoma de Barcelona · ESUniversity of Pittsburgh · USCairo University · EGCentro Médico Nacional La Raza · MXFoundation University Medical College · PKFriedrich-Alexander-Universität Erlangen-Nürnberg · DEIstanbul University · TRKarolinska University Hospital · SEKing's College London · GBLozenetz Hospital · BGLund University · SEMaulana Azad Medical College · INMexican Social Security Institute · MXNational Institute for Health Research · GBNippon Medical School · JPPomeranian Medical University · PLSaint Joseph University · LBSkåne University Hospital · SE
Funding
Versus Arthritis 21992
Abstract
The coronavirus disease-2019 (COVID-19) pandemic continues to be a cause of unprecedented global morbidity and mortality. Whilst COVID-19 vaccination has emerged as the only tangible solution to reducing poor clinical outcomes, vaccine hesitancy continues to be an obstacle to achieving high levels of vaccine uptake. This represents particular risk to patients with autoimmune diseases, a group already at increased risk of hospitalization and poor clinical outcomes related to COVID-19 infection. Whilst there is a paucity of long-term safety and efficacy data of COVID-19 vaccination in patients with autoimmune diseases, the current evidence strongly suggests that the benefits of vaccination outweigh the risks of adverse effects and disease flares. Herein, we report the protocol of the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study, an ongoing international collaborative study involving 29 countries and over 110 investigators.
Indexed as
Autoimmune DiseasesCOVID-19COVID-19 VaccinesHealth Care SurveysHumansVaccinationVaccination HesitancyCOVID-19 VaccinesAutoimmune diseasesCOVADCOVID-19SurveyVaccination
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.